These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 20504763)

  • 1. Angiotensin-converting enzyme inhibition down-regulates the pro-atherogenic chemokine receptor 9 (CCR9)-chemokine ligand 25 (CCL25) axis.
    Abd Alla J; Langer A; Elzahwy SS; Arman-Kalcek G; Streichert T; Quitterer U
    J Biol Chem; 2010 Jul; 285(30):23496-505. PubMed ID: 20504763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deficiency in lymphotoxin β receptor protects from atherosclerosis in apoE-deficient mice.
    Grandoch M; Feldmann K; Göthert JR; Dick LS; Homann S; Klatt C; Bayer JK; Waldheim JN; Rabausch B; Nagy N; Oberhuber A; Deenen R; Köhrer K; Lehr S; Homey B; Pfeffer K; Fischer JW
    Circ Res; 2015 Apr; 116(8):e57-68. PubMed ID: 25740843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of beta7 integrin and the chemokine/chemokine receptor pair CCL25/CCR9 in modeled TNF-dependent Crohn's disease.
    Apostolaki M; Manoloukos M; Roulis M; Wurbel MA; Müller W; Papadakis KA; Kontoyiannis DL; Malissen B; Kollias G
    Gastroenterology; 2008 Jun; 134(7):2025-35. PubMed ID: 18439426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monocytes/macrophages express chemokine receptor CCR9 in rheumatoid arthritis and CCL25 stimulates their differentiation.
    Schmutz C; Cartwright A; Williams H; Haworth O; Williams JH; Filer A; Salmon M; Buckley CD; Middleton J
    Arthritis Res Ther; 2010; 12(4):R161. PubMed ID: 20738854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of CC chemokine receptor 9 in the progression of murine and human non-alcoholic steatohepatitis.
    Morikawa R; Nakamoto N; Amiya T; Chu PS; Koda Y; Teratani T; Suzuki T; Kurebayashi Y; Ueno A; Taniki N; Miyamoto K; Yamaguchi A; Shiba S; Katayama T; Yoshida K; Takada Y; Ishihara R; Ebinuma H; Sakamoto M; Kanai T
    J Hepatol; 2021 Mar; 74(3):511-521. PubMed ID: 33038434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCL25/CCR9 interactions regulate the function of iNKT cells in oxazolone-induced colitis in mice.
    Zhu S; Bing Y; Wang X; Yu Q; Wang Y; Xu S; Song L; Wang X; Xia B; Zhu Y; Zhou R
    PLoS One; 2014; 9(6):e100167. PubMed ID: 24936795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and histopathological correlation of CCR9 and CCL25 in ovarian cancer.
    Singh R; Stockard CR; Grizzle WE; Lillard JW; Singh S
    Int J Oncol; 2011 Aug; 39(2):373-81. PubMed ID: 21637913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired CCR9/CCL25 signalling induced by inefficient dendritic cells contributes to intestinal immune imbalance in nonalcoholic steatohepatitis.
    Gao W; Wang Y; Bi J; Chen X; Li N; Wang Y; Tang H; Mao J
    Biochem Biophys Res Commun; 2021 Jan; 534():34-40. PubMed ID: 33310185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCR9-CCL25 interaction suppresses apoptosis of lung cancer cells by activating the PI3K/Akt pathway.
    Li B; Wang Z; Zhong Y; Lan J; Li X; Lin H
    Med Oncol; 2015 Mar; 32(3):66. PubMed ID: 25691296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCL25-CCR9 interaction modulates ovarian cancer cell migration, metalloproteinase expression, and invasion.
    Johnson EL; Singh R; Singh S; Johnson-Holiday CM; Grizzle WE; Partridge EE; Lillard JW
    World J Surg Oncol; 2010 Jul; 8():62. PubMed ID: 20649989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abrogation of CC chemokine receptor 9 ameliorates collagen-induced arthritis of mice.
    Yokoyama W; Kohsaka H; Kaneko K; Walters M; Takayasu A; Fukuda S; Miyabe C; Miyabe Y; Love PE; Nakamoto N; Kanai T; Watanabe-Imai K; Charvat TT; Penfold ME; Jaen J; Schall TJ; Harigai M; Miyasaka N; Nanki T
    Arthritis Res Ther; 2014 Sep; 16(5):445. PubMed ID: 25248373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokine (C-C motif) ligand 25 expressed by trophoblast cells and leukocytes bearing its receptor Ccr9: An alliance during embryo implantation?
    Weingrill RB; Hoshida MS; Martinhago CD; Correa-Silva S; Cardoso E; Palmeira P; Marinho CRF; Bevilacqua E
    Am J Reprod Immunol; 2018 Jan; 79(1):. PubMed ID: 29154408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACE inhibition lowers angiotensin II-induced chemokine expression by reduction of NF-kappaB activity and AT1 receptor expression.
    Schmeisser A; Soehnlein O; Illmer T; Lorenz HM; Eskafi S; Roerick O; Gabler C; Strasser R; Daniel WG; Garlichs CD
    Biochem Biophys Res Commun; 2004 Dec; 325(2):532-40. PubMed ID: 15530425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-C motif chemokine receptor 9 regulates obesity-induced insulin resistance via inflammation of the small intestine in mice.
    Amiya T; Nakamoto N; Irie J; Taniki N; Chu PS; Koda Y; Miyamoto K; Yamaguchi A; Shiba S; Morikawa R; Itoh H; Kanai T
    Diabetologia; 2021 Mar; 64(3):603-617. PubMed ID: 33399911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular expression profile and clinical significance of the CCR9-CCL25 chemokine receptor complex in nasopharyngeal carcinoma.
    Ye LF; Huang J; Zhang LP; Chen Z
    J Laryngol Otol; 2015 Oct; 129(10):1013-9. PubMed ID: 26279399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCL25/CCR9 interactions are not essential for colitis development but are required for innate immune cell protection from chronic experimental murine colitis.
    Wurbel MA; Le Bras S; Ibourk M; Pardo M; McIntire MG; Coco D; Geha RS; Fiebiger E; Snapper SB
    Inflamm Bowel Dis; 2014 Jul; 20(7):1165-76. PubMed ID: 24874458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratumoral delivery of CCL25 enhances immunotherapy against triple-negative breast cancer by recruiting CCR9
    Chen H; Cong X; Wu C; Wu X; Wang J; Mao K; Li J; Zhu G; Liu F; Meng X; Song J; Sun X; Wang X; Liu S; Zhang S; Yang X; Song Y; Yang YG; Sun T
    Sci Adv; 2020 Jan; 6(5):eaax4690. PubMed ID: 32064335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological inhibition of the chemokine receptor, CX3CR1, reduces atherosclerosis in mice.
    Poupel L; Boissonnas A; Hermand P; Dorgham K; Guyon E; Auvynet C; Charles FS; Lesnik P; Deterre P; Combadiere C
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2297-305. PubMed ID: 23887641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCR9 mediates PI3K/AKT-dependent antiapoptotic signals in prostate cancer cells and inhibition of CCR9-CCL25 interaction enhances the cytotoxic effects of etoposide.
    Sharma PK; Singh R; Novakovic KR; Eaton JW; Grizzle WE; Singh S
    Int J Cancer; 2010 Nov; 127(9):2020-30. PubMed ID: 20127861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocyte-macrophage colony stimulating factor blockade promotes ccr9(+) lymphocyte expansion in Nod2 deficient mice.
    Samson CM; Jurickova I; Molden E; Schreiner W; Colliver J; Bonkowski E; Han X; Trapnell BC; Denson LA
    Inflamm Bowel Dis; 2011 Dec; 17(12):2443-55. PubMed ID: 21381154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.